Validating New Avenues in Characterization and Treatment of Pediatric Glioblastoma

Validating New Avenues in Characterization and Treatment of Pediatric Glioblastoma

Validating New Avenues in Characterization and Treatment of Pediatric Glioblastoma


Dr. Balraj Jhawar

Windsor Regional Hospital



FUNDER: ChildCan

DURATION: 2026-2027

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Related Programs:
Nucleus Cores:

A collaborative team of local and international researchers, alongside a person with lived experience, is investigating whether glioblastoma, an aggressive brain cancer, differs across age groups. Using patient-derived organoids and advanced imaging, the team will examine tumour growth and behaviour in pediatric, adolescent/young adult, and adult patients, then apply machine learning to create detailed 3D tumour maps and identify patterns linked to clinical and molecular characteristics.

This research could improve understanding of how glioblastoma develops across the lifespan, helping identify age-specific disease patterns and informing more personalized approaches to diagnosis and treatment.

Co-Investigators:

University of Windsor

  • Dr. Dorota Lubanska
  • Dr. Lisa Porter

Collaborator:

Cairo University

  • Dr. Mohamed Soliman

Cincinnati Children's Hospital Medical Centre

  • Dr. Keith Stringer

OncoBridge Bio

  • Dr. Srinath Kandalam

Patient Partner:

  • McKenna Lumley
Loading...